BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17471156)

  • 1. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
    Greiner TC
    Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
    Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
    Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
    Loyant V; Jaffré A; Breton J; Baldi I; Vital A; Chapon F; Dutoit S; Lecluse Y; Loiseau H; Lebailly P; Gauduchon P
    Mutagenesis; 2005 Sep; 20(5):365-73. PubMed ID: 16105905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
    Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
    Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
    O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
    Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.
    Holmila R; Husgafvel-Pursiainen K
    Cancer Detect Prev; 2006; 30(1):1-6. PubMed ID: 16458448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
    Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
    J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of GC clamps in DHPLC mutation scanning.
    Wurzburger RJ; Gupta R; Parnassa AP; Jain S; Wexler JA; Chu JL; Elkon KB; Blank RD
    Clin Med Res; 2003 Apr; 1(2):111-8. PubMed ID: 15931297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
    Fackenthal DL; Chen PX; Das S
    Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations.
    Meierhofer D; Mayr JA; Ebner S; Sperl W; Kofler B
    Mitochondrion; 2005 Aug; 5(4):282-96. PubMed ID: 16050991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of DNA polymerases on mutation screening of denaturing high-performance liquid chromatography].
    Liu MR; Pan KF; Wang Y; Lu YY
    Ai Zheng; 2002 Oct; 21(10):1160-3. PubMed ID: 12508666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography.
    Biggin A; Henke R; Bennetts B; Thorburn DR; Christodoulou J
    Mol Genet Metab; 2005 Jan; 84(1):61-74. PubMed ID: 15639196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
    Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
    Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
    Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
    Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denaturing HPLC for mutation screening.
    Mitchell M; Cutler J
    Methods Mol Biol; 2011; 688():17-33. PubMed ID: 20938830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.